Thermo Fisher Scientific Inc
TMO570.330USD
-5.580-0.97%
收盤 12/16, 16:00（美東）報價延遲15分鐘
214.28B總市值
32.91本益比TTM
關於 Thermo Fisher Scientific Inc 公司
Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. It also provides purification and filtration technologies.
Thermo Fisher Scientific Inc簡介
公司代碼TMO
公司名稱Thermo Fisher Scientific Inc
上市日期Aug 27, 1980
CEOCasper (Marc N)
員工數量125000
證券類型Ordinary Share
年結日Aug 27
公司地址168 Third Avenue
城市WALTHAM
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編02451
電話17816221000
網址https://corporate.thermofisher.com/us/en/index.html
公司代碼TMO
上市日期Aug 27, 1980
CEOCasper (Marc N)
Thermo Fisher Scientific Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Marc N. Casper
Mr. Marc N. Casper
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
112.55K
--
Mr. Michel Lagarde
Mr. Michel Lagarde
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
73.38K
+475.77%
Mr. Scott M. Sperling
Mr. Scott M. Sperling
Lead Independent Director
Lead Independent Director
73.03K
+0.78%
Mr. Stephen Williamson
Mr. Stephen Williamson
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
37.08K
-1.15%
Mr. Michael D. Shafer
Mr. Michael D. Shafer
Executive Vice President
Executive Vice President
18.98K
--
Mr. Nelson J. Chai
Mr. Nelson J. Chai
Independent Director
Independent Director
14.48K
+4.06%
Mr. Gianluca Pettiti
Mr. Gianluca Pettiti
Executive Vice President
Executive Vice President
11.48K
--
Ms. Lisa P. Britt
Ms. Lisa P. Britt
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
10.66K
-20.84%
Mr. Michael A. Boxer
Mr. Michael A. Boxer
Senior Vice President, General Counsel
Senior Vice President, General Counsel
8.87K
-29.85%
Dr. Tyler Jacks
Dr. Tyler Jacks
Director
Director
8.62K
+7.01%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Marc N. Casper
Mr. Marc N. Casper
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
112.55K
--
Mr. Michel Lagarde
Mr. Michel Lagarde
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
73.38K
+475.77%
Mr. Scott M. Sperling
Mr. Scott M. Sperling
Lead Independent Director
Lead Independent Director
73.03K
+0.78%
Mr. Stephen Williamson
Mr. Stephen Williamson
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
37.08K
-1.15%
Mr. Michael D. Shafer
Mr. Michael D. Shafer
Executive Vice President
Executive Vice President
18.98K
--
Mr. Nelson J. Chai
Mr. Nelson J. Chai
Independent Director
Independent Director
14.48K
+4.06%
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Consumables
4.61B
42.43%
Service
4.61B
42.42%
Instruments
1.64B
15.15%
地區USD
名稱
營收
佔比
North America
5.72B
52.71%
Europe
2.83B
26.07%
Asia Pacific
1.92B
17.69%
Other Regions
383.00M
3.53%
業務
地區
業務USD
名稱
營收
佔比
Consumables
4.61B
42.43%
Service
4.61B
42.42%
Instruments
1.64B
15.15%
股東統計
更新時間: 11月16日 週日
更新時間: 11月16日 週日
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
8.96%
BlackRock Institutional Trust Company, N.A.
4.55%
State Street Investment Management (US)
4.36%
Capital World Investors
2.74%
Geode Capital Management, L.L.C.
2.17%
其他
77.22%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
8.96%
BlackRock Institutional Trust Company, N.A.
4.55%
State Street Investment Management (US)
4.36%
Capital World Investors
2.74%
Geode Capital Management, L.L.C.
2.17%
其他
77.22%
股東類型
持股股東
佔比
Investment Advisor
50.57%
Investment Advisor/Hedge Fund
30.17%
Pension Fund
2.80%
Bank and Trust
2.73%
Research Firm
2.62%
Hedge Fund
1.91%
Sovereign Wealth Fund
1.86%
Family Office
0.20%
Family Office
0.20%
其他
6.92%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
4341
344.96M
91.81%
-9.54M
2025Q2
4335
351.93M
93.19%
-4.42M
2025Q1
4395
350.27M
92.78%
-5.82M
2024Q4
4330
349.72M
92.67%
-4.90M
2024Q3
4195
348.49M
91.10%
-6.75M
2024Q2
4169
349.06M
91.37%
-3.26M
2024Q1
4150
346.74M
90.80%
-11.10M
2023Q4
4145
353.49M
91.48%
-3.65M
2023Q3
4035
353.30M
91.43%
-5.83M
2023Q2
4030
357.37M
92.63%
+1.15M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
33.62M
8.9%
+304.63K
+0.91%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
16.94M
4.49%
-335.33K
-1.94%
Jun 30, 2025
State Street Investment Management (US)
16.48M
4.36%
-58.52K
-0.35%
Jun 30, 2025
Capital World Investors
9.58M
2.54%
-1.48M
-13.41%
Jun 30, 2025
Geode Capital Management, L.L.C.
8.11M
2.15%
-12.40K
-0.15%
Jun 30, 2025
Fidelity Management & Research Company LLC
3.22M
0.85%
-727.96K
-18.43%
Jun 30, 2025
T. Rowe Price Associates, Inc.
5.00M
1.32%
-3.74M
-42.82%
Jun 30, 2025
Morgan Stanley Smith Barney LLC
5.61M
1.49%
+1.13M
+25.29%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
5.59M
1.48%
-469.24K
-7.75%
Jun 30, 2025
Putnam Investment Management, L.L.C.
3.35M
0.89%
+55.55K
+1.69%
Jun 30, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
VanEck Morningstar Wide Moat Value ETF
5.72%
Goldman Sachs Future Health Care Equity ETF
5.09%
Honeytree US Equity ETF
4.9%
Parnassus Value Select ETF
4.52%
Health Care Select Sector SPDR Fund
4.39%
Proshares Ultra Health Care
4.24%
iShares U.S. Healthcare ETF
4.2%
AdvisorShares Focused Equity ETF
4.01%
GMO US Quality ETF
4%
Brookstone Value Stock ETF
3.97%
查看更多
VanEck Morningstar Wide Moat Value ETF
佔比5.72%
Goldman Sachs Future Health Care Equity ETF
佔比5.09%
Honeytree US Equity ETF
佔比4.9%
Parnassus Value Select ETF
佔比4.52%
Health Care Select Sector SPDR Fund
佔比4.39%
Proshares Ultra Health Care
佔比4.24%
iShares U.S. Healthcare ETF
佔比4.2%
AdvisorShares Focused Equity ETF
佔比4.01%
GMO US Quality ETF
佔比4%
Brookstone Value Stock ETF
佔比3.97%
分紅派息
近5年累計派現
2.29B
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Jul 10, 2025
TMO.NB Final Cash Dividend of gross USD 0.43 paid on Oct 15, 2025 going ex on Sep 15, 2025
Sep 15, 2025
Oct 15, 2025
Sep 15, 2025
May 21, 2025
TMO.NB Interim Cash Dividend of gross USD 0.43 paid on Jul 15, 2025 going ex on Jun 13, 2025
Jun 13, 2025
Jul 15, 2025
Jun 13, 2025
Feb 19, 2025
TMO.NB Interim Cash Dividend of gross USD 0.43 paid on Apr 15, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 15, 2025
Mar 14, 2025
Nov 07, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jan 15, 2025 going ex on Dec 13, 2024
Dec 13, 2024
Jan 15, 2025
Dec 13, 2024
Jul 11, 2024
TMO.NB Final Cash Dividend of gross USD 0.39 paid on Oct 15, 2024 going ex on Sep 13, 2024
Sep 13, 2024
Oct 15, 2024
Sep 13, 2024
May 22, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jul 15, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 15, 2024
Jun 14, 2024
Feb 21, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Apr 15, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 15, 2024
Mar 14, 2024
Nov 09, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jan 16, 2024 going ex on Dec 14, 2023
Dec 15, 2023
Jan 16, 2024
Dec 14, 2023
Jul 13, 2023
TMO.NB Final Cash Dividend of gross USD 0.35 paid on Oct 13, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 13, 2023
Sep 14, 2023
May 24, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jul 14, 2023 going ex on Jun 14, 2023
Jun 15, 2023
Jul 14, 2023
Jun 14, 2023
查看更多
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
常見問題
Thermo Fisher Scientific Inc的前五大股東是誰？
Thermo Fisher Scientific Inc的前五大股東如下：
The Vanguard Group, Inc.持有股份：33.62M佔總股份比例：8.90%。
BlackRock Institutional Trust Company, N.A.持有股份：16.94M佔總股份比例：4.49%。
State Street Investment Management (US)持有股份：16.48M佔總股份比例：4.36%。
Capital World Investors持有股份：9.58M佔總股份比例：2.54%。
Geode Capital Management, L.L.C.持有股份：8.11M佔總股份比例：2.15%。
The Vanguard Group, Inc.持有股份：33.62M佔總股份比例：8.90%。
BlackRock Institutional Trust Company, N.A.持有股份：16.94M佔總股份比例：4.49%。
State Street Investment Management (US)持有股份：16.48M佔總股份比例：4.36%。
Capital World Investors持有股份：9.58M佔總股份比例：2.54%。
Geode Capital Management, L.L.C.持有股份：8.11M佔總股份比例：2.15%。
Thermo Fisher Scientific Inc的前三大股東類型是什麼？
Thermo Fisher Scientific Inc 的前三大股東類型分別是：
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
有多少機構持有Thermo Fisher Scientific Inc(TMO)的股份？
截至2025Q3，共有4341家機構持有Thermo Fisher Scientific Inc的股份，合計持有的股份價值約為344.96M，占公司總股份的91.81% 。與2025Q2相比，機構持股有所增加，增幅為-1.39%。
哪個業務部門對Thermo Fisher Scientific Inc的收入貢獻最大？
在FY2025Q2，Consumables業務部門對Thermo Fisher Scientific Inc的收入貢獻最大，創收4.61B，占總收入的42.43% 。
